Tectonic Therapeutic, Inc..
TECX.US | Research and experimental development on natural sciences and engineering
Tectonic Therapeutic, Inc. is a biopharmaceutical company focused on discovering and developing novel, disease-modifying therapeutics by leveraging its GEODe platform. This platform is designed to identify and exploit allosteric binding sites on proteins, enabling the creation of innovative therapie...Show More
Better Health for All
40
Tectonic Therapeutic's core business is entirely dedicated to discovering and developing novel therapeutic proteins and antibodies for diseases with high unmet medical needs, such as Group 2 Pulmonary Hypertension-Heart Failure with Preserved Ejection Fraction (PH-HFpEF) affecting over 600,000 people in the U.S., and Hereditary Hemorrhagic Telangiectasia (HHT) affecting an estimated 70,000 people in the U.S.
1
The company has no revenue from products with negative health outcomes. All of its capital, including $80 million in Series A financing and a $130.7 million private placement, totaling approximately $181 million in cash, cash equivalents, and investments, is allocated to health innovation.
2
The company's Phase Ia trial for TX45 indicated minimal adverse events and no evidence of immune-mediated clearance.
3
Its Phase II trial for TX45 is a randomized, placebo-controlled trial that received US FDA clearance for the investigational new drug application.
4
Fair Money & Economic Opportunity
0
No evidence available to assess Tectonic Therapeutic, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, quantitative data points were found in the provided articles to assess the company against the defined KPIs for Fair Pay & Worker Respect. While the company's Code of Business Conduct and Ethics outlines commitments to non-discrimination, occupational health and safety, and a respectful workplace, these are policy statements and do not provide measurable outcomes such as living wage coverage, pay ratios, safety incident rates, or labor violation incidents.
1
CEO pay was reported as $5,900,979 in 2024, but median employee compensation was not provided, preventing the calculation of a CEO-to-median-pay ratio.
2
Fair Trade & Ethical Sourcing
0
Tectonic Therapeutic, Inc. is a biopharmaceutical company focused on research and experimental development.
1
Given this operational profile, the company does not appear to procure or trade physical commodities, nor does it have a supplier base requiring welfare or sourcing audits, or exposure to upstream labor practices typically associated with fair trade and ethical sourcing. Therefore, several KPIs are assessed as N/A. No specific data was found regarding ethical clause coverage or supplier diversity spend to allow for scoring these KPIs.
2
Honest & Fair Business
-30
The company has a Code of Business Conduct and Ethics that applies to all employees, officers, and directors, requiring annual acknowledgment.
1
It includes a Whistleblower Policy for accounting and auditing matters, a toll-free anonymous hotline, and a non-retaliation clause.
2
The Audit Committee oversees investigations, and annual training on the Code is conducted.
3
The company also has an anti-corruption policy that explicitly mentions compliance with the U.S. Foreign Corrupt Practices Act (FCPA) and prohibits improper payments to government officials, requiring approval for gifts and hospitality.
4
However, the effectiveness of the anti-corruption training is not publicly measured.
Kind to Animals
-60
The company conducts animal testing, including preclinical studies and nonclinical safety pharmacology and toxicology testing, and a 4-week non-human primate dose-range study.
1
It also references long-term animal studies in a mouse model.
2
The company's policy states a commitment to conducting research ethically, at the highest scientific standards, and in compliance with all applicable regulatory requirements, including animal welfare standards.
3
However, no specific animal testing volume is disclosed, nor are there transparent reduction targets.
4
The company's R&D expenses for the nine months ended September 30, 2024, were $32.208 million, but no percentage of this is allocated to animal-free technologies.
5
No War, No Weapons
0
Tectonic Therapeutic, Inc. is a biopharmaceutical company focused on developing novel therapeutics.
1
The provided articles discuss the company's merger, financing, and clinical drug development.
2
None of the articles contain any specific, concrete data points or information related to the company's involvement in arms manufacturing, military contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, or any other metrics relevant to the 'No War, No Weapons' ethical value.
3
Therefore, all KPIs are scored as N/A, indicating no defense or arms-related activities in its core business.
Planet-Friendly Business
0
No specific, concrete data points were found in the provided articles for Tectonic Therapeutic, Inc. (TECX.US) regarding any of the Planet-Friendly Business KPIs. The articles either discuss sustainability efforts of other companies (Integra Therapeutics, AstraZeneca, or other ocean-based climate solution companies),
1
focus on services offered by a similarly named but distinct entity (TectonicTeam),
2
or provide only financial results for TECX.US without any environmental, social, or governance (ESG) information.
3
Respect for Cultures & Communities
0
No evidence available to assess Tectonic Therapeutic, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
The company states it is in material compliance with all applicable data privacy and security laws and regulations, including HIPAA and GDPR, and has taken all necessary actions to comply.
1
It implements commercially reasonable technical, administrative, and physical measures to protect personal data.
2
The company does not knowingly collect personal data from children under the age of 16.
3
A Cookie Preference Center is available for users to manage their cookie consent preferences.
4
The company's Code of Business Conduct and Ethics states it protects personal data and uses it in accordance with policies, procedures, and applicable laws.
5
Privacy considerations are integrated into the development process, with the company stating it owns or has the right to use intellectual property necessary to conduct its business as currently conducted and as proposed to be conducted.
6
Zero Waste & Sustainable Products
0
No specific, quantitative data for TECX.US regarding waste diversion rates, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education was found in the provided articles. The articles either explicitly state that no data is provided for TECX.US or discuss general industry trends and pilot programs not directly attributable to the company.